These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 25654244
21. Subjective effects of cannabis before the first psychotic episode. Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415 [Abstract] [Full Text] [Related]
22. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi K, Bertani M, Bissoli S, Lazzarotto L, Marrella G, Lamonaca D, Riolo R, Gardellin F, Urbani A, Tansella M, Ruggeri M, PICOS-VENETO Group. J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558 [Abstract] [Full Text] [Related]
23. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D. Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298 [Abstract] [Full Text] [Related]
24. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Meijer JH, Dekker N, Koeter MW, Quee PJ, van Beveren NJ, Meijer CJ, Genetic Risk and Outcome of Psychosis (GROUP) Investigators. Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795 [Abstract] [Full Text] [Related]
25. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I, GROUP Investigators. Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790 [Abstract] [Full Text] [Related]
27. Cannabis as a risk factor for psychosis: systematic review. Semple DM, McIntosh AM, Lawrie SM. J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146 [Abstract] [Full Text] [Related]
28. Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms. Reeves LE, Anglin DM, Heimberg RG, Gibson LE, Fineberg AM, Maxwell SD, Kerns CM, Ellman LM. Psychiatry Res; 2014 Aug 15; 218(1-2):180-6. PubMed ID: 24745470 [Abstract] [Full Text] [Related]
30. Cannabis use in people with severe mental illness: The association with physical and mental health--a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study. Bruins J, Pijnenborg MG, Bartels-Velthuis AA, Visser E, van den Heuvel ER, Bruggeman R, Jörg F. J Psychopharmacol; 2016 Apr 15; 30(4):354-62. PubMed ID: 26883305 [Abstract] [Full Text] [Related]
35. Cannabis use and expression of mania in the general population. Henquet C, Krabbendam L, de Graaf R, ten Have M, van Os J. J Affect Disord; 2006 Oct 15; 95(1-3):103-10. PubMed ID: 16793142 [Abstract] [Full Text] [Related]
37. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Psychol Med; 2012 Jun 15; 42(6):1321-8. PubMed ID: 21999906 [Abstract] [Full Text] [Related]
38. Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study. Kapfhammer HP, Reininghaus EZ, Fitz W, Lange P. J Clin Psychiatry; 2014 Oct 15; 75(10):1096-104. PubMed ID: 25373118 [Abstract] [Full Text] [Related]